Use of eltrombopag in aplastic anemia in EuropeJakob Passweg, Matyas Ecsedi, Étienne Lengliné et al.|Annals of Hematology|2019Cited by 38
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactionsAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Anna Ferrari et al.|Journal of Translational Medicine|2024Cited by 5